OR WAIT null SECS
© 2023 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2023 MJH Life Sciences™ and Formulary Watch. All rights reserved.
January 25, 2023
The Inflation Reduction Act’s cap on annual out-of-pocket spending and changes to coverage gaps could save Medicare patients more than $1,000 on heart failure medications.
The Association for Accessible Medicines’ report indicates plans, especially those in Medicare, are slower to prefer first generics.
January 24, 2023
Amazon Prime members can access generic medications from an eligible list with free delivery for an additional $5 a month.
Price Edge compares direct-to-consumer pricing with insurance pricing for generic drugs. It is an optional product being offered to plans.
January 23, 2023
Dea Belazi of AscellaHealth talks about the challenges payers will face as they confront the high costs associated with specialty drugs.
January 19, 2023
Annual savings from biosimilars could be more $100 billion by 2026, according to IQVIA’s latest Global Use of Medicines report.
January 18, 2023
Patient advocates discussed the difficulties that formulary policies and lack of transparency place on those with chronic disease at an ICER sponsored webinar.
The Inflation Reduction Act’s cap on out-of-pocket costs for insulin is likely to improve outcomes for almost half of Medicare’s insulin users.
January 17, 2023
While ICER found that overall major payer coverage policies are in line with the organization’s fair access criteria, many payers do not provide adequate transparency into clinical coverage criteria.
January 16, 2023
A new membership program, SmartRx, offers consumers savings on prescriptions, as well as office visits, eye care, vaccines and pet meds.